Literature DB >> 8229478

Neuropsychologic effects of stroke in children with sickle cell anemia.

S Craft1, J Schatz, T A Glauser, B Lee, M R DeBaun.   

Abstract

We examined the nature and extent of neuropsychologic impairment in children with sickle cell anemia (SCA) with or without stroke. Twenty-nine children with SCA received cranial magnetic resonance imaging. Strokes were classified into three groups: diffuse cortical stroke (n = 11), anterior stroke (n = 6), or none (n = 12). Children with SCA and 20 age-matched sibling control subjects then received a neurologic examination and a neuropsychologic battery of tests that included motor, verbal, spatial, attentional, and memory measures. Tests of spatial function showed that children with diffuse cortical strokes were impaired, whereas children with anterior lesions had intrusions of irrelevant material during list recall. There were no significant differences between children with stroke and sibling control subjects on motor, verbal, or memory measures. Six children had evidence of stroke on magnetic resonance imaging without any history of a damaging neurologic event. These children had impaired neuropsychologic performance relative to that of sibling control subjects in a pattern similar to that of children with overt stroke. Children with SCA without stroke did not differ from sibling control subjects on any measure. Our results indicate that overt and silent strokes result in lesion-specific neuropsychologic deficits in children with SCA.

Entities:  

Mesh:

Year:  1993        PMID: 8229478     DOI: 10.1016/s0022-3476(05)80844-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  8 in total

Review 1.  Stroke in children with sickle cell anaemia: aetiology and treatment.

Authors:  C H Pegelow
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 2.  Neuropsychological aspects of pediatric sickle cell disease.

Authors:  M C Kral; R T Brown; G W Hynd
Journal:  Neuropsychol Rev       Date:  2001-12       Impact factor: 7.444

3.  Design of the silent cerebral infarct transfusion (SIT) trial.

Authors:  James F Casella; Allison A King; Bruce Barton; Desiree A White; Michael J Noetzel; Rebecca N Ichord; Cindy Terrill; Deborah Hirtz; Robert C McKinstry; John J Strouse; Thomas H Howard; Thomas D Coates; Caterina P Minniti; Andrew D Campbell; Bruce A Vendt; Harold Lehmann; Michael R Debaun
Journal:  Pediatr Hematol Oncol       Date:  2010-03       Impact factor: 1.969

Review 4.  Considerations for Selecting Cognitive Endpoints and Psychological Patient-Reported Outcomes for Clinical Trials in Pediatric Patients With Sickle Cell Disease.

Authors:  Anna M Hood; Lori E Crosby; Hanne Stotesbury; Melanie Kölbel; Fenella J Kirkham
Journal:  Front Neurol       Date:  2022-06-21       Impact factor: 4.086

Review 5.  Hypoxia and inflammation in children with sickle cell disease: implications for hippocampal functioning and episodic memory.

Authors:  Mary Iampietro; Tania Giovannetti; Reem Tarazi
Journal:  Neuropsychol Rev       Date:  2014-04-18       Impact factor: 7.444

6.  Vascular Instability and Neurological Morbidity in Sickle Cell Disease: An Integrative Framework.

Authors:  Hanne Stotesbury; Jamie M Kawadler; Patrick W Hales; Dawn E Saunders; Christopher A Clark; Fenella J Kirkham
Journal:  Front Neurol       Date:  2019-08-13       Impact factor: 4.003

7.  Intellectual function evaluation of first generation immigrant children with sickle cell disease: the role of language and sociodemographic factors.

Authors:  Maria Montanaro; Raffaella Colombatti; Marisa Pugliese; Camilla Migliozzi; Fabiana Zani; Maria Elena Guerzoni; Sheila Manoli; Renzo Manara; Giorgio Meneghetti; Patrizia Rampazzo; Francesca Cavalleri; Marco Giordan; Paolo Paolucci; Giuseppe Basso; Giovanni Palazzi; Laura Sainati
Journal:  Ital J Pediatr       Date:  2013-06-04       Impact factor: 2.638

8.  Psychiatric problems in children and adolescents with sickle cell disease, based on parent and teacher reports.

Authors:  Ozalp Ekinci; Tanju Celik; Sule Unal; Cahit Ozer
Journal:  Turk J Haematol       Date:  2012-10-05       Impact factor: 1.831

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.